364 related articles for article (PubMed ID: 7480685)
1. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
Korobkin M; Lombardi TJ; Aisen AM; Francis IR; Quint LE; Dunnick NR; Londy F; Shapiro B; Gross MD; Thompson NW
Radiology; 1995 Nov; 197(2):411-8. PubMed ID: 7480685
[TBL] [Abstract][Full Text] [Related]
2. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies.
Krestin GP; Steinbrich W; Friedmann G
Radiology; 1989 Jun; 171(3):675-80. PubMed ID: 2717737
[TBL] [Abstract][Full Text] [Related]
3. Characterization of adrenal masses using MR imaging with histopathologic correlation.
Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
Nakahara H; Noguchi S; Murakami N; Tamura S; Jinnouchi S; Kodama T; Adjei ON; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
Radiology; 1997 Mar; 202(3):765-72. PubMed ID: 9051032
[TBL] [Abstract][Full Text] [Related]
6. Fatty tissue on opposed-phase MR images: paradoxical suppression of signal intensity by paramagnetic contrast agents.
Mitchell DG; Stolpen AH; Siegelman ES; Bolinger L; Outwater EK
Radiology; 1996 Feb; 198(2):351-7. PubMed ID: 8596831
[TBL] [Abstract][Full Text] [Related]
7. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
8. Combined chemical shift imaging with early dynamic serial gadolinium-enhanced MRI in the characterization of adrenal lesions.
Rodacki K; Ramalho M; Dale BM; Battisti S; de Campos RO; Giardino A; Semelka RC
AJR Am J Roentgenol; 2014 Jul; 203(1):99-106. PubMed ID: 24951201
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-enhanced MR imaging of the spleen: artifacts and potential pitfalls.
Ito K; Mitchell DG; Honjo K; Fujita T; Awaya H; Takano K; Koike S; Matsumoto T; Matsunaga N
AJR Am J Roentgenol; 1996 Nov; 167(5):1147-51. PubMed ID: 8911169
[No Abstract] [Full Text] [Related]
10. Value of chemical shift subtraction MRI in characterization of adrenal masses.
Savci G; Yazici Z; Sahin N; Akgöz S; Tuncel E
AJR Am J Roentgenol; 2006 Jan; 186(1):130-5. PubMed ID: 16357391
[TBL] [Abstract][Full Text] [Related]
11. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
[TBL] [Abstract][Full Text] [Related]
12. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
Schindera ST; Soher BJ; Delong DM; Dale BM; Merkle EM
Radiology; 2008 Jul; 248(1):140-7. PubMed ID: 18566172
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
14. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Peterson MS; Baron RL; Murakami T
Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
[TBL] [Abstract][Full Text] [Related]
15. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.
Namimoto T; Yamashita Y; Mitsuzaki K; Nakayama Y; Makita O; Kadota M; Takahashi M
Radiology; 2001 Mar; 218(3):642-6. PubMed ID: 11230633
[TBL] [Abstract][Full Text] [Related]
16. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
[TBL] [Abstract][Full Text] [Related]
17. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
Mihara F; Gupta KL; Righi AM
Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
[TBL] [Abstract][Full Text] [Related]
18. Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging.
Schwartz LH; Panicek DM; Koutcher JA; Brown KT; Getrajdman GI; Heelan RT; Burt M
Radiology; 1995 Nov; 197(2):421-5. PubMed ID: 7480686
[TBL] [Abstract][Full Text] [Related]
19. [Magnetic resonance tomography of adrenal gland tumors. Detection and differentiation using fast gradient echo sequences and dynamic contrast media studies].
Krestin GP; Lorenz R; Steinbrich W
Radiologe; 1990 May; 30(5):228-34. PubMed ID: 2356308
[TBL] [Abstract][Full Text] [Related]
20. Intracranial lesion enhancement with gadolinium: T1-weighted spin-echo versus three-dimensional Fourier transform gradient-echo MR imaging.
Mirowitz SA
Radiology; 1992 Nov; 185(2):529-34. PubMed ID: 1410367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
